James Campling
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 21, 2026
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.Diana Mendes, Ahuva Averin, Mark Atwood
|Oct 13, 2022
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease.Diana Mendes, Ahuva Averin, Mark Atwood
|Aug 05, 2022
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England.Tendai Mugwagwa, Ahuva Averin, Mark Atwood
|Jul 11, 2022
A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England.James Campling, Elizabeth Begier, Andrew Vyse
|Jun 21, 2022
Hospitalization costs of adult community-acquired pneumonia in England.James Campling, Hannah F Wright, Gillian C Hall
Pageof 1
Frequent Collaborators
5 joint publications
Andrew Vyse
4 joint publications
Tendai Mugwagwa
4 joint publications
Diana Mendes
4 joint publications
Gillian F Ellsbury
3 joint publications
Derek Weycker
3 joint publications
Mary Slack
3 joint publications
Reiko Sato
3 joint publications
Ahuva Averin
1 joint publications
Jeffrey Vietri
1 joint publications
Elizabeth Begier
